Bayer Competitors and Similar CompaniesClear all
Shionogi's competitors and similar companies include Astellas Pharma, AstraZeneca and Novartis.
 Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | |
Founding Date | Founding Date 1878 | Founding Date 1923 | Founding Date 1999 | Founding Date 1996 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more |
Employees | Employees 4,955 | Employees 14,754 | Employees 94,300 | Employees 75,883 |
Valuation ($) | Valuation ($) 12.3 b | Valuation ($) 20.8 b | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) ¥2.1t (FY, 2026) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) |
Cost of goods | Cost of goods ¥55.5b (FY, 2026) | Cost of goods ¥213.8b (FY, 2026) | Cost of goods $4.9b (FY, 2025) | Cost of goods $8.4b (FY, 2025) |
Gross profit | Gross profit ¥491.3b (FY, 2026) | Gross profit ¥2t (FY, 2026) | Gross profit $54.2b (FY, 2025) | Gross profit $49.8b (FY, 2025) |
Net income | Net income ¥205.9b (FY, 2026) | Net income ¥291.6b (FY, 2026) | Net income $10.2b (FY, 2025) | Net income $14b (FY, 2025) |
Operating ⚠ | ||||
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 4 (Oct, 2020) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 27 (FY, 2021) |
Funding | ||||
Total funding raised | Total funding raised $ 4.7m | Total funding raised N/A | Total funding raised $ 1b | Total funding raised $ 6.5m |
For sources of this data, please see the company profile
View Company Profiles
Astellas Pharma
HQ
Tokyo, JP
Employees
14,754
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company